nach oben

Erschienen in:

20.06.2016 | Original Paper

Bromfenac ophthalmic solution 0.09 %: human aqueous humor concentration detected by high-performance liquid chromatography

verfasst von: Angelo Macrì, Aldo Vagge, Annalisa Salis, Carmen Fucile, Valeria Marini, Antonietta Martelli, Sebastiano Giuffrida, Michele Iester, Gianluca Damonte, Francesca Mattioli

Erschienen in: International Ophthalmology | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

The purpose of this study was to evaluate the aqueous humor concentrations of bromfenac ophthalmic solution 0.09 % in patients undergoing phacoemulsification. Patients requiring cataract extraction received one drop (50 µL) of bromfenac 0.09 % solution in the eye to be operated, before bedtime the day before surgery or the morning of the surgery. The last administration was recorded. At the time of paracentesis, an aqueous humor sample was collected with a 30-gauge needle attached to a TB syringe and was later analyzed by high-performance liquid chromatography for drug concentration. 188 treated volunteers and 48 control, untreated, subjects were included in the study. The mean aqueous concentration of bromfenac in the treated group was 37.60 ± 68.86 and 0 nM (nmol/L) in the control group (p < 0.0001). Correlation coefficient in bromfenac group between time elapsed from instillation and drug concentration was −0.16 (p not significant). Bromfenac showed properties of good penetration and stable concentration in aqueous humor up to about 12 h after instillation.

Gupta S, Khurana AK, Ahluwalia BK, Gupta NC (1991) Topical indomethacin for vernal keratoconjunctivitis. Acta Ophthalmol 69:95–98CrossRef

Laibovitz RA, Koester J, Schaich L et al (1995) Safety and efficacy of diclofenac sodium 0.1% ophthalmic solution in acute seasonal allergic conjunctivitis. J Ocul Pharmacol Ther 11:361–368CrossRefPubMed

Tauber J, Raizman MB, Ostrov CS et al (1998) A multicenter comparison of the ocular efficacy and safety of diclofenac 0.1% solution with that of ketorolac 0.5% solution in patients with acute seasonal allergic conjunctivitis. J Ocul Pharmacol Ther 14:137–145CrossRefPubMed

Donnenfeld ED, Perry HD, Wittpenn JR et al (2006) Preoperative ketorolac tromethamine 0.4% in phacoemulsification outcomes: pharmacokinetic-response curve. J Cataract Refract Surg 32:1474–1482CrossRefPubMed

Roberts CW (1996) Pretreatment with topical diclofenac sodium to decrease postoperative inflammation. Ophthalmology 103:636–639CrossRefPubMed

Yavas GF, Ozturk F, Kusbeci T (2007) Preoperative topical indomethacin to prevent pseudophakic cystoid macular edema. J Cataract Refract Surg 33:804–807CrossRefPubMed

Kessel L, Kendal B, Jorgensen KJ et al (2014) Post-cataract prevention of inflammation and macular edema by steroid and nonsteroidal anti-inflammatory eye drops: a systematic review. Ophthalmology 121(10):1915–1924CrossRefPubMed

Renfro L, Snow JS (1992) Ocular effects of topical and systemic steroids. Dermatol Clin 10(3):505–512PubMed

McGhee CN (1992) Pharmacokinetics of ophthalmic corticosteroids. Br J Ophthalmol 76:681–684CrossRefPubMedPubMedCentral

10.

ESCRS Endophthalmitis Study Group (2007) Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors. J Cataract Refract Surg 33:978–988CrossRef

11.

Koay P (1996) The emerging roles of topical non-steroidal antiinflammatory agents in ophthalmology. Br J Ophthalmol 80:480–485CrossRefPubMedPubMedCentral

12.

Bucci FA Jr, Waterbury LD (2011) Prostaglandin E2 inhibition of ketorolac 0.45%, bromfenac 0.09%, and nepafenac 0.1% in patients undergoing phacoemulsification. Adv Ther 28(12):1089–1095CrossRefPubMed

13.

Baklayan GA, Muñoz M (2014) The ocular distribution of (14)C-labeled bromfenac ophthalmic solution 0.07% in a rabbit model. Clin Ophthalmol 8:1717–1724CrossRefPubMedPubMedCentral

14.

Oka T, Shearer T, Azuma M (2004) Involvement of cyclooxygenase-2 in rat models of conjunctivitis. Curr Eye Res 29(1):27–34CrossRefPubMed

15.

Miyamoto T, Saika S, Okada Y et al (2004) Expression of cyclooxygenase-2 in corneal cells after photorefractive keratectomy and laser in situ keratomileusis in rabbits. J Cataract Refract Surg 30(12):2612–2617CrossRefPubMed

16.

Radi ZA, Render JA. The pathophysiologic role of cyclo-oxygenases in the eye. J Ocul Pharmacol Ther. 2008;24(2):141–151)

17.

Ruiz J, López M, Milà J et al (1993) QSAR and conformational analysis of the anti-inflammatory agent amfenac and analogues. J Comput Aided Mol Des 7(2):183–198CrossRefPubMed

18.

Baklayan GA, Patterson HM, Song CK et al (2008) 24-hour evaluation of the ocular distribution of (14)C-labeled bromfenac following topical instillation into the eyes of New Zealand White rabbits. J Ocul Pharmacol Ther 24(4):392–398CrossRefPubMed

19.

Macri A, Marini V, Sangalli G et al (2015) An artificial aqueous humor as a standard matrix to assess drug concentration in the anterior chamber by high performance liquid chromatography methods. Clin Lab 61(1–2):47–52PubMed

20.

Miyake K (1977) Prevention of cystoid macular edema after lens extraction by topical indomethacin (I). A preliminary report. Albrecht Von Graefes Arch Klin Exp Ophthalmol 203(2):81–88CrossRefPubMed

21.

Kraff MC, Sanders DR, Jampol LM et al (1982) Prophylaxis of pseudophakic cystoid macular edema with topical indomethacin. Ophthalmology 89(8):885–890CrossRefPubMed

22.

Flach AJ (1998) The incidence, pathogenesis and treatment of cystoid macular edema following cataract surgery. Trans Am Ophthalmol Soc 96:557–634PubMedPubMedCentral

23.

Rossetti L, Chaudhuri J, Dickersin K (1998) Medical prophylaxis and treatment of cystoid macular edema after cataract surgery. Results Meta Anal Ophthalmol 105(3):397–405

24.

Rho DS (2003) Treatment of acute pseudophakic cystoid macular edema: Diclofenac versus ketorolac. J Cataract Refract Surg 29(12):2378–2384CrossRefPubMed

25.

Yannuzzi LA, Landau AN, Turtz AI (1981) Incidence of aphakic cystoid macular edema with the use of topical indomethacin. Ophthalmology 88(9):947–954CrossRefPubMed

26.

Friedlaender MH (2001) The current and future therapy of allergic conjunctivitis. Curr Opin Ophthalmol 1:375–379

27.

Friedlaender M (2001) Overview of ocular allergy treatment. Curr Allergy Asthma Rep. 1:375–379CrossRefPubMed

28.

Badalà F, Fioretto M, Macrì A (2004) Effect of topical 0.1% Indomethacin solution versus 0.1% Fluorometholon on ocular surface and pain control following Laser Subepithelial Keratomileusis (LASEK). Cornea 23(6):550–553CrossRefPubMed

29.

Zanetti FR, Fulco EA, Chaves FR et al (2012) Effect of preoperative use of topical prednisolone acetate, ketorolac tromethamine, nepafenac and placebo, on the maintenance of intraoperative mydriasis during cataract surgery: a randomized trial. Indian J Ophthalmol 60(4):277–281CrossRefPubMedPubMedCentral

30.

Gayton J (2009) Concentration and dosing of ketorolac versus bromfenac. J Cataract Refract Surg 35(7):1319CrossRefPubMed

31.

Gluud BS, Jensen OL, Krogh E et al (1985) Prostaglandin E2 level in tears during postoperative inflammation of the eye. Acta Ophthalmol 63(4):375–379CrossRef

32.

Yanni JM, Graff G, Hellberg MR (1995) Adminstering 3-benzoylphenylacetamide derivatives. United States patent US5475034

33.

Miyake K, Ogawa T, Tajika T et al (2008) Ocular pharmacokinetics of a single dose of bromfenac sodium ophthalmic solution 0.1% in human aqueous humor. J Ocul Pharmacol Ther 24(6):573–578CrossRefPubMed

Titel: Bromfenac ophthalmic solution 0.09 %: human aqueous humor concentration detected by high-performance liquid chromatography
verfasst von: Angelo Macrì
Aldo Vagge
Annalisa Salis
Carmen Fucile
Valeria Marini
Antonietta Martelli
Sebastiano Giuffrida
Michele Iester
Gianluca Damonte
Francesca Mattioli
Publikationsdatum: 20.06.2016
Verlag: Springer Netherlands
Erschienen in: International Ophthalmology / Ausgabe 2/2017
Print ISSN: 0165-5701
Elektronische ISSN: 1573-2630
DOI: https://doi.org/10.1007/s10792-016-0279-3

Neu im Fachgebiet Augenheilkunde

08.04.2024 | Therapieverfahren in der Augenheilkunde | CME

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Bromfenac ophthalmic solution 0.09 %: human aqueous humor concentration detected by high-performance liquid chromatography

Abstract

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Bakterielle endogene Endophthalmitis

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Update Augenheilkunde

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2017

Two-spatulae maneuver to intraocularly flip a reverse-opened, foldable intraocular lens

Overcorrecting minus lens therapy in patients with intermittent exotropia: Should it be the first therapeutic choice?

Safety and complications of intravitreal injections performed in an Asian population in Singapore

Comparison of pain experience during 23-G vitreoretinal surgery under topical and retrobulbar anesthesia

A novel method to reduce noise in electroretinography using skin electrodes: a study of noise level, inter-session variability, and reproducibility

Visual consequences of electronic reader use: a pilot study

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Bakterielle endogene Endophthalmitis

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Update Augenheilkunde